Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Pontevedra (25)

2024

  1. A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma

    Frontiers in Immunology, Vol. 15

  2. Dispersal history of SARS-CoV-2 in Galicia, Spain

    Journal of Medical Virology, Vol. 96, Núm. 7

2023

  1. Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study

    ESC Heart Failure, Vol. 10, Núm. 5, pp. 3055-3066

  2. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

2022

  1. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  2. The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

    Frontiers in Physiology, Vol. 12

2018

  1. Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage

    Therapeutic Advances in Cardiovascular Disease, Vol. 12, Núm. 2, pp. 53-72

  2. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry

    Cardiology Journal, Vol. 25, Núm. 3, pp. 353-362

2016

  1. Influencia del índice de masa corporal en el pronóstico de pacientes con desfibrilador automático implantable en prevención primaria de muerte súbita

    Revista Espanola de Cardiologia, Vol. 69, Núm. 10, pp. 990-992

2015

  1. Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients

    Current Pharmacogenomics and Personalized Medicine, Vol. 13, Núm. 1, pp. 61-67

2014

  1. Contrast-induced nephropathy and bleeding: A bidirectional link with prognostic value in acute coronary syndrome

    International Journal of Cardiology, Vol. 176, Núm. 1, pp. 235-236

2013

  1. Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs

    Journal of Allergy and Clinical Immunology, Vol. 132, Núm. 4, pp. 989-991

  2. Cambios electrocardiográficos durante la prueba de esfuerzo en un paciente con patrón electrocardiográfico tipo 1 de Brugada: Una curiosidad con implicaciones clínicas

    Revista Espanola de Anestesiologia y Reanimacion

  3. GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function

    Angiology, Vol. 64, Núm. 1, pp. 31-39

  4. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 117-122

  5. New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients

    Pharmacogenomics, Vol. 14, Núm. 6, pp. 631-640

2012

  1. Advanced glycation end products: A mysterious shadow beyond the relationship between HbA1c and atrial fibrillation

    International Journal of Cardiology, Vol. 157, Núm. 3, pp. 441

  2. High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score

    Angiology, Vol. 63, Núm. 1, pp. 30-34

2011

  1. Diagnóstico de arteritis de Takayasu a los 64 años: ¿vale la pena pararse en la exploración física?

    Revista Clinica Espanola